Navigation Links
King's to develop unique sunscreen with Aethic
Date:9/11/2012

King's College London has entered into an agreement with skincare company Aethic to develop the first sunscreen based on MAA's (mycosporine-like amino acids), produced by coral.

It was last year that a team led by Dr Paul Long at King's discovered how the naturally-occurring MAA's were produced. Algae living within coral make a compound that is transported to the coral, which then modifies it into a sunscreen for the benefit of both the coral and the algae. Not only does this protect them both from UV damage, but fish that feed on the coral also benefit from this sunscreen protection.

The next phase of development is for the researchers to work with Professor Antony Young and colleagues at the St John's Institute of Dermatology at King's, to test the efficacy of the compounds using human skin models.

Aethic's Sve sunscreen was selected as the best 'host' product for the compound because of its existing broad-spectrum UVA/UVB and photo-stability characteristics and scientifically proven ecocompatibility credentials.

Dr Paul Long, Reader in Pharmacognosy at King's Institute of Pharmaceutical Science, said: "While MAA's have a number of other potential applications, human sunscreen is certainly a good place to begin proving the compound's features. If our further studies confirm the results we are expecting, we hope that we will be able to develop a sunscreen with the broadest spectrum of protection. Aethic has the best product and philosophy with which to proceed this exciting project."

Allard Marx, CEO of Aethic, added: "With the recent launch of Sve we believe that we are already leading the industry. Together with King's we would like to raise our product benefits to an even higher level using MAA's. We are very excited about the potential."


'/>"/>
Contact: Emma Reynolds
emma.reynolds@kcl.ac.uk
44-207-848-4334
King's College London
Source:Eurekalert

Page: 1

Related medicine news :

1. Tumor cells inner workings predict cancer progression
2. LWW announces 57% growth in 2011 impact factor rankings
3. Former Vikings and NFL Greats Tackle Sleep Apnea at Upcoming Minneapolis Event
4. Strategy developed to improve delivery of medicines to the brain
5. New collaboration to develop treatments for liver disease
6. Kids Develop Sense of Humor by Age 1, Study Finds
7. Multi-functional anti-inflammatory/anti-allergic developed by Hebrew University researcher
8. New genetic clues to why most bone marrow transplant patients develop graft-versus-host disease
9. A model for development
10. NIH scientists map first steps in flu antibody development
11. Adelaide joins with Italy to develop super spaghetti
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2017)... ... June 26, 2017 , ... ... is revolutionizing the way women look and feel about themselves and their sexual ... female sexual dysfunction and urinary leakage head on with a ground breaking medical ...
(Date:6/26/2017)... Antonio, TX (PRWEB) , ... June 26, 2017 ... ... physicians, their coding staff, and consumers are seeing lots of red these days. ... receive contain inaccurate charges that result from medical coding errors(1). Some studies point ...
(Date:6/26/2017)... Fitchburg, WI (PRWEB) , ... June 26, 2017 , ... ... implant consultations from Dr. Angela Cotey, with or without a referral. Dr. Cotey is ... the benefits of this preferred tooth replacement option. , Patients with missing teeth in ...
(Date:6/25/2017)... Viejo, CA (PRWEB) , ... June 24, 2017 , ... Create a feel-good lyric music ... presets above footage and sound in the timeline and write in the lyrics to any ... before flying back out. Each line of the text can be added modularly for optimal ...
(Date:6/25/2017)... ... 25, 2017 , ... An increase in wetter weather in the Northern California ... with that; a humdinger of an allergy season. A relief from drought conditions is ... misery-causing grass and weed pollen. , “Our patients have been reporting the typical ...
Breaking Medicine News(10 mins):
(Date:6/3/2017)... June 3, 2017  Eli Lilly and Company ... results from the Phase 3 MONARCH 2 study ... 6 inhibitor, in combination with fulvestrant, significantly improved ... alone in women with hormone-receptor-positive (HR+), human epidermal ... who have relapsed or progressed after endocrine therapy ...
(Date:5/30/2017)... Hill-Rom Holdings, Inc. (NYSE: HRC), will present at ... on Tuesday, June 13, 2017, in Rancho Palos ... and chief executive officer, is scheduled to present at 3:20 ... be accessed at http://ir.hill-rom.com/events.cfm . A recorded replay will ... through September 13, 2017. ...
(Date:5/26/2017)... Calif. , May 25, 2017  In response ... States , Direct Relief is working with Pfizer ... Naloxone available at no cost to community health centers, ... nonprofit providers nationwide. "Pfizer has a ... to medicines and ensuring patient safety through educational activities," ...
Breaking Medicine Technology: